Related Experiment Video
Updated: Aug 29, 2026
A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft
Published on: February 14, 2022
Haptoglobin phenotype correlates with development of cardiac transplant vasculopathy
Cameron G Densem1, Julie Wassel, Ann Cooper
1Cardiothoracic Transplant Unit, Wythenshawe Hospital, Manchester, UK.
Insights
Haptoglobin phenotype variation is linked to cardiac transplant vasculopathy development. Recipients with the 2-1 phenotype showed a higher likelihood of developing this condition, impacting long-term survival.
Area of Science:
- Cardiology
- Immunogenetics
- Transplantation Medicine
Background:
- Coronary vasculopathy significantly impacts long-term survival post-cardiac transplantation.
- Serum haptoglobin, involved in hemoglobin binding and oxidative stress, influences atherosclerosis.
- Human haptoglobin exhibits three phenotypes (1-1, 2-1, 2-2) with distinct quantitative and qualitative properties.
Purpose of the Study:
- To investigate the association between haptoglobin phenotypic variation and the development of cardiac transplant vasculopathy.
- To explore the role of different haptoglobin phenotypes in post-transplant coronary artery disease.
Main Methods:
- Coronary disease was assessed via routine surveillance angiography post-transplantation.
- Haptoglobin phenotypes were determined by electrophoretic separation of hemoglobin complexes.
- Haptoglobin concentrations were quantified using an immunoturbidimetric assay.
Main Results:
- Haptoglobin levels were highest in phenotype 1-1 recipients, followed by 2-1 and 2-2.
- A significant association was observed between haptoglobin phenotype and vasculopathy development (p=0.0084).
- Multivariate analysis identified donor age, recipient BMI, and haptoglobin phenotype as independent risk factors for vasculopathy.
Conclusions:
- Haptoglobin phenotype is correlated with coronary vasculopathy development through phenotype-dependent mechanisms.
- This finding enhances understanding of transplant vasculopathy pathogenesis.
- Potential for novel therapeutic strategies targeting haptoglobin phenotypes in transplant recipients.
Objectives:
The purpose of this study was to investigate the association between haptoglobin phenotypic variation and development of cardiac transplant vasculopathy.
Background:
The development of coronary vasculopathy determines long-term survival after cardiac transplantation. Serum haptoglobin levels are associated with non-transplant atherosclerosis. In addition to free hemoglobin binding, haptoglobin influences free radical formation, prostaglandin synthesis and angiogenesis. Three phenotypes of haptoglobin exist in humans, which have both quantitative and qualitative differences.
Methods:
Coronary disease was diagnosed at post-transplant routine surveillance angiography. Hemoglobin (10%) was added to recipient plasma to form a haptoglobin-hemoglobin complex. Sample aliquots were applied to acid hemoglobin plates and electrophoretically separated. Phenotypes were recognized by comparing the electrophoretic pattern with that of established standards. Haptoglobin concentrations were measured using an immunoturbidimetric technique with polyethylene glycol (PEG)-enhanced precipitation.
Results:
Ninety-three patients were independently studied. Phenotype 1-1 was found in 20.4%, 2-1 in 41.9% and 2-2 in 37.6%. Haptoglobin levels were highest in 1-1 recipients (2.1 +/- 0.58 g/liter) compared with 1.78 +/- 0.88 g/liter and 1.3 +/- 0.81 g/liter in 2-1 and 2-2 individuals, respectively (p = 0.001). Haptoglobin phenotype was significantly related to the development of vasculopathy; recipients with a 2-1 phenotype were more likely to develop angiographic disease (p = 0.0084). No differences were found among the 3 groups according to univariate analysis. Multivariate analysis identified 3 risk factors for vasculopathy development: age of donor (hazard ratio 1.056 [95% confidence interval 1.02 to 1.094], p = 0.0023); pre-transplant recipient body mass index (hazard ratio 1.116 [95% confidence interval 1.015 to 1.23], p = 0.024), and haptoglobin phenotype (hazard ratio 2.725 [95% confidence interval 1.031 to 7.19], p = 0.012).
Conclusions:
Haptoglobin, through phenotype-dependent mechanisms, correlates with the development of coronary vasculopathy. This finding furthers our understanding of the disease, opens up new areas of research, and may lead to novel therapies.
Related Concept Videos
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
01:24Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
01:28Kidney Transplant I: Introduction
01:29Cardiomyopathy V: Interprofessional Care